Candel Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold CADL, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

20
Funds holding
$108325217
Total value held
Buying
18 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $51181112 4969040 +1859998 +59.83%
2 State Street Corp $36563177 3549823 +2731265 +333.67%
3 Northern Trust Corp $5072389 492465 +169311 +52.39%
4 Goldman Sachs Group Inc $3143724 305216 +77695 +34.15%
5 Bank Of America Corp /De/ $2873123 278944 +231542 +488.46%
6 Bank Of New York Mellon Corp $1974516 191701 +55435 +40.68%
7 Ubs Group Ag $1743491 169271 +169271 NEW BUY
8 Morgan Stanley $1299294 126145 +67916 +116.64%
9 Citigroup Inc $880753 85510 +82836 +3097.83%
10 Janus Henderson Group Plc $845272 171978 +171978 NEW BUY
11 Wells Fargo & Company/Mn $592250 57500 +40907 +246.53%
12 Sei Investments Co $441973 42910 +42910 NEW BUY
13 Raymond James Financial Inc $431900 41932 +1932 +4.83%
14 Barclays Plc $406232 39440 +27741 +237.12%
15 Invesco Ltd. $388444 37713 +37713 NEW BUY
16 Jpmorgan Chase & Co $338088 32634 +7771 +31.26%
17 Prudential Financial Inc $113352 11005 +11005 NEW BUY
18 Royal Bank Of Canada $28000 2727 +2127 +354.50%
19 Us Bancorp \De\ $7200 699 -32 -4.38%
20 Pnc Financial Services Group, Inc. $927 90 -64 -41.56%

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.